Altimmune, Inc. (ALT)
3.25
+0.02
(+0.62%)
USD |
NASDAQ |
Sep 16, 14:17
Altimmune Market Cap : 632.04M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 628.15M |
| September 14, 2026 | 641.76M |
| September 11, 2026 | 635.93M |
| September 10, 2026 | 639.82M |
| September 09, 2026 | 651.49M |
| September 08, 2026 | 653.43M |
| September 04, 2026 | 665.10M |
| September 03, 2026 | 628.15M |
| September 02, 2026 | 637.88M |
| September 01, 2026 | 600.93M |
| August 31, 2026 | 604.81M |
| August 28, 2026 | 604.81M |
| August 27, 2026 | 630.10M |
| August 26, 2026 | 612.59M |
| August 25, 2026 | 622.32M |
| August 24, 2026 | 604.81M |
| August 21, 2026 | 604.81M |
| August 20, 2026 | 573.70M |
| August 19, 2026 | 606.76M |
| August 18, 2026 | 577.59M |
| August 17, 2026 | 583.42M |
| August 14, 2026 | 571.75M |
| August 13, 2026 | 560.09M |
| August 12, 2026 | 569.81M |
| August 11, 2026 | 583.42M |
| Date | Value |
|---|---|
| August 10, 2026 | 593.15M |
| August 07, 2026 | 598.98M |
| August 06, 2026 | 391.97M |
| August 05, 2026 | 394.57M |
| August 04, 2026 | 399.78M |
| August 03, 2026 | 390.66M |
| July 31, 2026 | 369.83M |
| July 30, 2026 | 388.06M |
| July 29, 2026 | 380.25M |
| July 28, 2026 | 389.36M |
| July 27, 2026 | 385.45M |
| July 24, 2026 | 360.71M |
| July 23, 2026 | 369.83M |
| July 22, 2026 | 365.92M |
| July 21, 2026 | 367.22M |
| July 20, 2026 | 365.92M |
| July 17, 2026 | 373.73M |
| July 16, 2026 | 371.13M |
| July 15, 2026 | 388.06M |
| July 14, 2026 | 381.55M |
| July 13, 2026 | 389.36M |
| July 10, 2026 | 397.17M |
| July 09, 2026 | 406.29M |
| July 08, 2026 | 404.99M |
| July 07, 2026 | 393.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Protalix Biotherapeutics, Inc. | 212.71M |
| Taysha Gene Therapies, Inc. | 1.631B |
| Humacyte, Inc. | 161.12M |
| Liquidia Corp. | 6.154B |
| Agenus, Inc. | 305.98M |
Market Cap Related Metrics
| PS Ratio | 13103.18 |
| Price to Book Value | 1.333 |
| Price | 3.25 |
| Earnings Yield | -24.27% |